Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.32 INR -0.81% Market Closed
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note

Intrinsic Value

524663 doesn't have a meaningful market cap.

The intrinsic value of one BIBCL stock under the Base Case scenario is 4.55 INR. Compared to the current market price of 23.32 INR, Bharat Immunologicals and Biologicals Corporation Ltd is Overvalued by 80%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIBCL Intrinsic Value
4.55 INR
Overvaluation 80%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bharat Immunologicals and Biologicals Corporation Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BIBCL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BIBCL?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Bharat Immunologicals and Biologicals Corporation Ltd

Provide an overview of the primary business activities
of Bharat Immunologicals and Biologicals Corporation Ltd.

What unique competitive advantages
does Bharat Immunologicals and Biologicals Corporation Ltd hold over its rivals?

What risks and challenges
does Bharat Immunologicals and Biologicals Corporation Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide P/S
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide P/E
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide P/OCF
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide P/FCFE
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide P/B
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/S
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/GP
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/EBITDA
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/EBIT
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/OCF
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/FCFF
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide EV/IC
for Bharat Immunologicals and Biologicals Corporation Ltd.

Compare the intrinsic valuations
of Bharat Immunologicals and Biologicals Corporation Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bharat Immunologicals and Biologicals Corporation Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bharat Immunologicals and Biologicals Corporation Ltd compared to its peers.

Compare the P/E ratios
of Bharat Immunologicals and Biologicals Corporation Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Bharat Immunologicals and Biologicals Corporation Ltd with its peers.

Analyze the financial leverage
of Bharat Immunologicals and Biologicals Corporation Ltd compared to its main competitors.

Show all profitability ratios
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide ROE
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide ROA
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide ROIC
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide ROCE
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Gross Margin
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Operating Margin
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Net Margin
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide FCF Margin
for Bharat Immunologicals and Biologicals Corporation Ltd.

Show all solvency ratios
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide D/E Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide D/A Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Interest Coverage Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Altman Z-Score Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Quick Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Current Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

Provide Cash Ratio
for Bharat Immunologicals and Biologicals Corporation Ltd.

What is the historical Revenue growth
over the last 5 years for Bharat Immunologicals and Biologicals Corporation Ltd?

What is the historical Net Income growth
over the last 5 years for Bharat Immunologicals and Biologicals Corporation Ltd?

What is the current Free Cash Flow
of Bharat Immunologicals and Biologicals Corporation Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bharat Immunologicals and Biologicals Corporation Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bharat Immunologicals and Biologicals Corporation Ltd

Current Assets 327.1m
Cash & Short-Term Investments 89.1m
Receivables 100.3m
Other Current Assets 137.8m
Non-Current Assets 1.6B
Long-Term Investments 92.8m
PP&E 1.2B
Other Non-Current Assets 309.2m
Current Liabilities 990.5m
Accounts Payable 7.8m
Short-Term Debt 708.6m
Other Current Liabilities 274.1m
Non-Current Liabilities 103.7m
Long-Term Debt 35m
Other Non-Current Liabilities 68.7m
Efficiency

Earnings Waterfall
Bharat Immunologicals and Biologicals Corporation Ltd

Revenue
76.5m INR
Cost of Revenue
-218.1m INR
Gross Profit
-141.6m INR
Operating Expenses
-61.2m INR
Operating Income
-202.8m INR
Other Expenses
18m INR
Net Income
-184.8m INR

Free Cash Flow Analysis
Bharat Immunologicals and Biologicals Corporation Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BIBCL Profitability Score
Profitability Due Diligence

Bharat Immunologicals and Biologicals Corporation Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score

Bharat Immunologicals and Biologicals Corporation Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

BIBCL Solvency Score
Solvency Due Diligence

Bharat Immunologicals and Biologicals Corporation Ltd's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
22/100
Solvency
Score

Bharat Immunologicals and Biologicals Corporation Ltd's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIBCL Price Targets Summary
Bharat Immunologicals and Biologicals Corporation Ltd

There are no price targets for BIBCL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIBCL?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIBCL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd

Country

India

Industry

Biotechnology

Market Cap

1B INR

Dividend Yield

0%

Description

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacture and market of pharmaceutical products. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into Plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

Contact

UTTAR PRADESH
Bulandshahr
OPV Plant, Village Chola
+917500241125
www.bibcol.com

IPO

1994-08-04

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one BIBCL stock?

The intrinsic value of one BIBCL stock under the Base Case scenario is 4.55 INR.

Is BIBCL stock undervalued or overvalued?

Compared to the current market price of 23.32 INR, Bharat Immunologicals and Biologicals Corporation Ltd is Overvalued by 80%.

Back to Top